Streetbeat News

Products Services

SKIN

The Beauty Health Company (NASDAQ:SKIN) has announced the placement of its 30,000th Hydrafacial delivery system, marking a significant milestone for the company's global omnichannel footprint. The company's Hydrafacial treatment is available in over 90 countries across various channels. A recent study by IPSOS showed that Hydrafacial's brand awareness reached 41% among U.S. consumers of the aesthetics category. The company also recently launched Hydrafacial Syndeo, a digitally connected delivery system.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 12:07 pm

BSGM

BioSig has released new software features for its PURE EP platform. These features were used for the first time in patient cases at the Kansas City Heart Rhythm Institute.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 12:06 pm

GERN

The FDA has assigned a standard review and a Prescription Drug User Fee Act action date of June 16, 2024, for Geron's new drug application for Imetelstat for transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes. The FDA also plans to hold an advisory committee meeting as part of the NDA review.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 12:03 pm

CABA

Cabaletta Bio and WuXi Advanced Therapies have expanded their GMP manufacturing agreement to include CABA-201. WuXi ATU will serve as a cell processing manufacturing partner for the global clinical development of CABA-201 in multiple indications, including potential late-stage clinical trials and commercial readiness activities.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 12:02 pm

ZEV

Lightning eMotors, a provider of commercial electric vehicles, has announced that its fielded units have surpassed 5 million real-world miles. This milestone indicates the company's growth and the increasing adoption of its electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 12:02 pm

STHZF

StateHouse Holdings Inc. (OTCQX:STHZF) (CSE:STHZ) has entered into a managed service agreement with Pelorus Capital Group to manage operations at Willow Creek, a cannabis cultivation facility in Humboldt County. The agreement includes a range of services such as human resources, legal and compliance, post-harvest production and processing, contract manufacturing, distribution and safety management. The CEO of StateHouse, Ed Schmults, believes this arrangement can unlock significant opportunities to provide managed services to other owners in the state and across the country.

Portfolio Pulse from Vuk Zdinjak

August 22, 2023 | 11:54 am

LLY

Eli Lilly and Company (NYSE:LLY) announced positive topline results from the LIBRETTO-531 study evaluating Retevmo versus physician's choice of the multikinase inhibitors (MKIs) cabozantinib or vandetanib for patients with advanced or metastatic rearranged during transfection (RET)-mutant medullary thyroid cancer (MTC). The study met its primary endpoint, showing a significant and clinically meaningful improvement in progression-free survival (PFS).

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 11:47 am

SNAP

Snapchat, owned by Snap Inc (NYSE:SNAP), is developing a new feature called 'Dreams' that uses AI to allow users to create new images within imagined scenarios. The company is also working on 'Dreams with Friends', which allows friends to co-create AI-induced images. Additionally, there are hints about 'Dream Packs' being available for purchase, indicating potential monetization avenues for the feature.

Portfolio Pulse from Sudhanshu Singh

August 22, 2023 | 11:36 am

MTNB

Matinas Biopharma announced that researchers from the University of Minnesota Medical School have published results from the Phase 2 EnACT trial evaluating Mat2203 for Cryptococcal Meningitis. The results were published as a major article and editor's choice in Clinical Infectious Diseases.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 11:32 am

SXTP

60 Degrees Pharmaceuticals has received an additional US patent for Tafenoquine, a drug used for the prevention of Plasmodium Falciparum Malaria. The patent will strengthen the company's intellectual property rights and potentially increase its market share.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 11:31 am